SCHEMBL5232178

SCHEMBL5232178

O=C(c1c(Br)ccc2c1OCO2)c1cccc2cnccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROS1 P08922 1/20 0.36
RPS6KB1 P23443 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPKAPK2 P49137 1/20 0.36
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
CNR2 P34972 3/20 0.35
CNR1 P21554 2/20 0.35
SSTR4 P31391 1/20 0.35
MAPT P10636 1/20 0.35
IDO1 P14902 1/20 0.35
AOC3 Q16853 1/20 0.34
CHEK1 O14757 1/20 0.34
PIM1 P11309 1/20 0.34
CDK8 P49336 1/20 0.34
GSK3B P49841 1/20 0.34
CDK7 P50613 1/20 0.34
CDK9 P50750 1/20 0.34
LIMK1 P53667 1/20 0.34
ROCK1 Q13464 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3676496 0.76 KDM4E (0.36) ROS1RPS6KB1KDM4EMAPKAPK2IDO1
SCHEMBL27967472 0.75 AOC3 (0.50) KDM4EALDH1A1RAB9AMAPTAOC3
SCHEMBL3672089 0.74 AOC3 (0.44) ROS1RPS6KB1KDM4EMAPKAPK2ALDH1A1
SCHEMBL27598089 0.73 KDM4E (0.58) KDM4EMAPKAPK2ALDH1A1CNR2CNR1
Alcohol SCHEMBL3675269 0.72 OPRM1 (0.34) ROS1RPS6KB1KDM4EMAPKAPK2ALDH1A1
SCHEMBL3971384 0.70 KDM4E (0.43) KDM4EMAPKAPK2ALDH1A1RAB9AMAPT
SCHEMBL17028220 0.69 KDM4E (0.41) ROS1RPS6KB1KDM4EMAPKAPK2ALDH1A1
SCHEMBL423788 0.68 AOC3 (0.49) KDM4EALDH1A1RAB9AMAPTAOC3
SCHEMBL12071539 0.66 AOC3 (0.47) KDM4EALDH1A1RAB9AMAPTAOC3
SCHEMBL422232 0.66 AOC3 (0.47) KDM4EALDH1A1RAB9AMAPTAOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1320367-A4 PROCESS FOR THE PREPARATION OF DINAPSOLINE PURDUE RESEARCH FOUNDATION (US) 2007-01-17 EP disclosed
US-6645975-B1 Reducing, deprotecting and optionally alkylating chemical intermediates to form 8,9-dihydroxy-2,3,7,11b-tetrahydro-1H-naphtho(1,2,3-de)isoquinoline, used as dopamine receptor agonists PURDUE RESEARCH FOUNDATION 2003-11-11 US disclosed
EP-1320367-A1 PROCESS FOR THE PREPARATION OF DINAPSOLINE PURDUE RESEARCH FOUNDATION (US) 2003-06-25 EP disclosed
WO-2002013827-A1 PROCESS FOR THE PREPARATION OF DINAPSOLINE PURDUE RESEARCH FOUNDATION (US) 2002-02-21 WO disclosed